𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reference distributions for complement proteins C3 and C4: A practical, simple and clinically relevant approach in a large cohort

✍ Scribed by Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas B. Ledue; Wendy Y. Craig


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
154 KB
Volume
18
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute‐phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring several days rather than hours to be detectably elevated by serial measurements. As with other acute‐phase proteins, there are many processes that up‐ or down‐regulate synthesis, including infection or inflammation, hepatic failure, and immune‐complex formation. Clinicians may find it difficult to distinguish among these processes, because they often occur simultaneously. The situation is further complicated by genetic polymorphism, with rare instances of markedly reduced synthesis and circulating levels, and consequent vulnerability to infection. C3 and C4 are measured for clinical purposes to help define certain rheumatic and immunologically mediated renal diseases. Interpreting the measured blood levels of these two components requires one to consider the intensity of the inflammatory drive, the timing of the suspected clinical process, the production of complement‐consuming immune complexes, and the possible existence of benign circumstances. In this fifth article in a series, reference ranges for serum levels of two complement proteins (C3 and C4) are examined. The study is based on a cohort of over 55,000 Caucasian individuals from northern New England, who were tested in our laboratory in 1994–1999. Measurements were standardized against certified reference material (CRM) 470/reference preparation for proteins in human serum (RPPHS), and analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C‐reactive protein of 10 mg/L or higher) were excluded. Our results show that the levels of C3 and C4 change little during life and between the sexes, except that they increase slightly and then fall after age 20 in males and at about age 45 in females. When values were expressed as multiples of the age‐ and gender‐specific median levels, the resulting distributions fitted a log‐Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement, thus simplifying interpretation. J. Clin. Lab. Anal. 18:1–8, 2004. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Reference distributions for alpha2-macro
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract In this 11th article in a series, reference values of serum levels alpha~2~‐macroglobulin α~2~M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New England that were tested in our laboratory between 1994 and 2000. Measurements were standardize

Reference distributions for immunoglobul
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Serum immunoglobulins are measured millions of times each year, yet clinical interpretations remain hampered by inadequate age- and gender-specific reference limits. In order to provide more reliable and comprehensive reference distributions for IgA, IgG, and IgM measurements, we analyzed automated

Reference distributions for serum iron a
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract The principal considerations driving iron status evaluation are clinical concern for anemia and the possibility of iron‐storage disease. Most often, the circulating levels of transferrin (or total iron binding capacity) and serum iron are measured and the percentage of transferrin satur

Reference distributions for the negative
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Inflammation is associated with diverse clinical conditions accompanied by characteristic changes in serum levels of the acutephase proteins that can be used to stage the inflammatory process and evaluate the impact of treatment. Some acute-phase proteins increase during inflammation, while others,

Reference distributions for complement p
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract The lack of credible reference materials and satisfactory methods for quantifying serum levels has limited the bedside use of complement protein (C3 and C4) measurements. However, great technological strides have been made in the last few years. The remaining barrier to a more relevant

Reference distributions for apolipoprote
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Thomas B. Ledue; Wendy Y. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

## Abstract The two serum apolipoproteins in the highest concentrations, apolipoprotein (apo) AI and apolipoprotein B, and the apolipoprotein B/AI ratio are measured to assess clinical risk for atherosclerotic heart and peripheral vascular diseases. The study is based on a cohort of over 37,000 Cau